Search Results - "Brügemann, J"

Heart transplantation in the Netherlands: A national achievement by Damman, K., Brügemann, J., De Boer, R. A., Erasmus, M. E., van den Broek, S. A. J.

Get full text

Life is Movement (Aristotle, 4th century BC) by Brügemann, J., Gerds-Ploeger, H.

Get full text

The diagnosis of left ventricular assist device thrombosis by Gerds, H.Z.R., Brügemann, J., Rienstra, M., Erasmus, M.E.

“…The clinical course of a patient with a left ventricular assist device is described. A total of 6 weeks after device insertion, the lactate dehydrogenase (LDH)…”
Get full text

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study by Alings, M., Smit, M. D., Moes, M. L., Crijns, H. J. G. M., Tijssen, J. G. P., Brügemann, J., Hillege, H. L., Lane, D. A., Lip, G. Y. H., Smeets, J. R. L. M., Tieleman, R. G., Tukkie, R., Willems, F. F., Vermond, R. A., Van Veldhuisen, D. J., Van Gelder, I. C.

“…Background Rhythm control for atrial fibrillation (AF) is cumbersome because of its progressive nature caused by structural remodelling. Upstream therapy…”
Get full text

Alternatives for heart transplantation? by Brügemann, J.

“…Ventricular assist devices (VADs) have been used in the University Medical Centre Utrecht (UMCU) since 1993 to ‘bridge’ patients on the waiting list for heart…”
Get full text

Guidelines for heart transplantation by de Jonge, N., Kirkels, J. H., Klöpping, C., Lahpor, J. R., Caliskan, K., Maat, A. P. W. M., Brügemann, J., Erasmus, M. E., Klautz, R. J. M., Verwey, H. F., Oomen, A., Peels, C. H., Golüke, A. E. J., Nicastia, D., Koole, M. A. C., Balk, A. H. M. M.

“…Based on the changes in the field of heart transplantation and the treatment and prognosis of patients with heart failure, these updated guidelines were…”
Get full text

Differential effects of high-frequency versus low-frequency exercise training in rehabilitation of patients with coronary artery disease by Nieuwland, Wybe, Berkhuysen, Marike A, van Veldhuisen, Dirk J, Brügemann, Johan, Landsman, Martin L.J, van Sonderen, Eric, Lie, K.I, Crijns, Harry J.G.M, Rispens, Piet

“…OBJECTIVES We sought to study the influence of frequency of exercise training during cardiac rehabilitation on functional capacity (i.e., peak oxygen…”
Get full text

Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation by Tuinenburg, A E, Van Gelder, I C, Den Berg, M P Van, Brügemann, J, De Kam, P J, Crijns, H J G M

“…OBJECTIVE To investigate the occurrence of heart failure complications, and to identify variables that predict heart failure in patients with (recurrent)…”
Get full text

Long-term outcome of electrical cardioversion in patients with chronic atrial flutter by Crijns, H. J., Van Gelder, I. C., Tieleman, R. G., Brügemann, J., De Kam, P. J., Gosselink, A. T., Bink-Boelkens, M. T., Lie, K. I.

“…OBJECTIVE: To determine the long-term outcome of serial electrical cardioversion therapy in patients with chronic atrial flutter. DESIGN: Prospective study,…”
Get full text

Physical training in patients with chronic heart failure: An elaboration of the statements from the Committee on Cardiac Rehabilitation of the Netherlands Society of Cardiology and the Netherlands Heart Foundation and review of studies on physical training in chronic heart failure by Senden, P J, Mosterd, A, Brügemann, J

“…Chronic heart failure (CHF) can be defined as a complex of symptoms and signs caused by cardiac dysfunction. Dyspnoea on exertion, fatigue, reduced exercise…”
Get full text

Current treatment recommendations in antiarrhythmic therapy by VAN GELDER, I. C, BRÜGEMANN, J, CRIJNS, H. J. G. M

“…Over the past decade, various studies have demonstrated that class I antiarrhythmic drugs should be avoided in patients with heart failure, cardiac ischaemia…”
Get full text

Extracorporeal membrane oxygenation before induction of anesthesia in critically ill thoracic transplant patients by de Boer, Willem J, Waterbolk, Tjalling W, Brügemann, Johan, van der Bij, Wim, Huyzen, Robert J

“…Cardiorespiratory failure just before surgery in critically ill thoracic transplant patients can have catastrophic consequences. We judged the…”
Get full text

Long-term outcome after heart transplantation performed in the University Medical Centre Groningen by Brügemann, J, van der Horst, I C C, van Veldhuisen, D J, van den Broek, S A J, de Jonge-Weber, A T G, Ebels, T, Boonstra, P W, Zijlstra, F

“…Ten years ago, there was a difference of opinion about the suitability of ventilated patients with end-stage cardiac failure for heart transplantation (HTX)…”
Get full text

Pharmacological management of arrhythmias in the elderly by VAN GELDER, I. C, BRÜGEMANN, J, CRIJNS, H. J. G. M

“…The incidence of cardiac arrhythmia increases with advancing age, as does the prevalence of structural heart disease. Serious arrhythmias, such as sustained…”
Get full text

Logistical problems in prehospital thrombolysis by Brügemann, J, van der Meer, J, de Graeff, P A, Takens, L H, Lie, K I

“…In this study we compared efficacy and safety of prehospital with in-hospital thrombolytic treatment with anistreplase in patients with acute myocardial…”
Get more information

Heart transplantation in the Netherlands by Damman, K, Brügemann, J, De Boer, R. A, Erasmus, M. E, van den Broek, S. A. J

“…Heart transplant survival has improved over time, despite a change in clinical characteristics such as increased donor age and more frequent use of left…”
Get full text

Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay by Brügemann, J, van der Meer, J, Bom, V J, Lie, K I

Get full text

The 4S study : Implications for prescribing by VAN BOVEN, A. J, BRÜGEMANN, J, DE GRAEFF, P. A, MAY, J. F, CRIJNS, H. J. G. M

“…This article discusses various aspects of cholesterol-lowering therapy using the HMG-CoA reductase inhibitor simvastatin in the light of the large Scandinavian…”
Get full text

Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients? by Brügemann, J, de Graeff, P A, van der Meer, J, Lie, K I

“…In patients with acute myocardial infarction (MI), quick initiation of thrombolytic therapy is the best strategy for improvement of survival and reduction of…”
Get full text

EXTENDED DONOR CRITERIA DO NOT AFFECT HEART TRANSPLANTATION OUTCOME: 423 by Heemskerk, M. B.A., Hemke, A. C., de Jonge, N., Balk, A. H.M.M., Brügemann, J., Haase-Kromwijk, B. J.J.M.

Get full text